Paul Ehrlich

By Lucía Cárdenas

Paul Ehrlich imagined the immune system as chemistry — locks and keys, magic bullets — and his imagination became medicine.

Born in 1854 in Strehlen, Silesia, Ehrlich was obsessed from his student days with dyes: how they stain some tissues and not others. The obsession became a worldview — if a dye binds selectively, a drug could too. Working with Koch in Berlin, he developed the staining methods that made the tuberculosis bacillus visible; then, with Behring, he worked on diphtheria antitoxin and formulated the side-chain theory: cells carry receptors, toxins bind them, and the cell responds by flooding the blood with free-floating receptors — antibodies. Immunity, in Ehrlich's picture, was molecular recognition, a chemistry of exquisite specificity. He won the 1908 Nobel Prize for it.

Then came the magic bullet. If dyes stain microbes selectively, Ehrlich reasoned, a poison attached to a selective dye would kill the microbe and spare the patient. He launched the first systematic drug hunt in history: his laboratory synthesized and tested hundreds of arsenic compounds against syphilis — compound 606 failed in trials, compound 914 was toxic — until number 606's successor, Salvarsan (compound 606 refined and stabilized), worked. In 1910 Salvarsan became the first effective cure for syphilis and the first modern chemotherapeutic drug: a synthetic molecule designed to seek and destroy a pathogen, the proof that chemistry could be aimed like a weapon.

Ehrlich was a chaotic, cigar-smoking, endlessly theorizing dynamo — colleagues joked that his ideas came faster than his experiments, and his laboratory notebooks overflowed with structures drawn before any test existed. He died in 1915, worn out by overwork. His magic bullet is the ancestor of every targeted drug: antibiotics, cancer chemotherapy, monoclonal antibodies — all of them Ehrlich's dream of a bullet that finds its target and nothing else.

Impact on civilization

Ehrlich founded immunology's molecular vision — antibodies as specific chemical receptors, the lock-and-key picture still taught today — and invented chemotherapy: the first systematic search for synthetic drugs that kill pathogens while sparing the patient. Salvarsan proved the magic-bullet concept; his receptor theory underlies vaccines, antitoxins, and monoclonal antibodies. Every targeted drug, from penicillin's successors to cancer immunotherapy to the monoclonal antibodies in today's pharmacies, descends from his idea that medicine can aim — the oldest dream of healing, made into chemistry.